Results 291 to 300 of about 13,757,225 (358)
Some of the next articles are maybe not open access.
The Lancet, 2023
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when ...
Wen-Juei, Jeng +2 more
openaire +2 more sources
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million people chronically infected and 820 000 deaths worldwide in 2019. Diagnosis of HBV infection requires serological testing for HBsAg and for acute infection additional testing for IgM hepatitis B core antibody (IgM anti-HBc, for the window period when ...
Wen-Juei, Jeng +2 more
openaire +2 more sources
Pediatric Clinics of North America, 1974
Viral hepatitis acquired after the neonatal period has been of two types, distinguished generally by their different incubation periods. Now better designated hepatitis A and hepatitis B, the history, clinical picture, differential diagnosis, and therapy of these disorders are discussed.
David H. Carver, Dexter S.Y. Seto
openaire +2 more sources
Viral hepatitis acquired after the neonatal period has been of two types, distinguished generally by their different incubation periods. Now better designated hepatitis A and hepatitis B, the history, clinical picture, differential diagnosis, and therapy of these disorders are discussed.
David H. Carver, Dexter S.Y. Seto
openaire +2 more sources
Drug and Alcohol Review, 1996
AbstractHepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide.
R G, Batey, S J, Bollipo
openaire +2 more sources
AbstractHepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide.
R G, Batey, S J, Bollipo
openaire +2 more sources
Infectious Disease Clinics of North America, 2000
The hepatitis B virus is a hepatotropic virus that can produce a variety of clinical syndromes in patients ranging in age from infants to elderly adults. Worldwide, it is among the leading causes of fulminant hepatic failure, cirrhosis, and hepatocellular carcinoma.
A S, Befeler, A M, Di Bisceglie
openaire +2 more sources
The hepatitis B virus is a hepatotropic virus that can produce a variety of clinical syndromes in patients ranging in age from infants to elderly adults. Worldwide, it is among the leading causes of fulminant hepatic failure, cirrhosis, and hepatocellular carcinoma.
A S, Befeler, A M, Di Bisceglie
openaire +2 more sources
Current Treatment Options in Gastroenterology, 1999
The management of acute HBV infection is supportive. Specific treatment is not indicated for HBV carriers because they often have no evidence of liver injury, and, further, do not respond to currently available therapies. Interferon monotherapy is best indicated for patients with chronic replicating HBV infection and evidence of chronic hepatitis ...
, Weakley, , Rajender Reddy K
openaire +2 more sources
The management of acute HBV infection is supportive. Specific treatment is not indicated for HBV carriers because they often have no evidence of liver injury, and, further, do not respond to currently available therapies. Interferon monotherapy is best indicated for patients with chronic replicating HBV infection and evidence of chronic hepatitis ...
, Weakley, , Rajender Reddy K
openaire +2 more sources
Journal, 2016
Laboratory confirmation of infection as demonstrated by: Hepatitis B surface antigen (HBsAg) positive PLUS immunoglobulin M antibody to hepatitis B core antigen (anti-HBc IgM) positive in the context of a compatible clinical history or probable ...
L. Gallagher
semanticscholar +1 more source
Laboratory confirmation of infection as demonstrated by: Hepatitis B surface antigen (HBsAg) positive PLUS immunoglobulin M antibody to hepatitis B core antigen (anti-HBc IgM) positive in the context of a compatible clinical history or probable ...
L. Gallagher
semanticscholar +1 more source
Nature, 1985
DNA recombinant technology has radically changed hepatitis B virus (HBV) virology. The genetic organization, transcription and replication of the virus are basically understood, structures of integrated HBV sequences in hepatocellular carcinoma have been characterized, and new vaccines produced by recombinant DNA technique are being developed.
Tiollais, Pierre +2 more
openaire +4 more sources
DNA recombinant technology has radically changed hepatitis B virus (HBV) virology. The genetic organization, transcription and replication of the virus are basically understood, structures of integrated HBV sequences in hepatocellular carcinoma have been characterized, and new vaccines produced by recombinant DNA technique are being developed.
Tiollais, Pierre +2 more
openaire +4 more sources
Clinics in Liver Disease, 2004
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Emmet B. Keeffe +3 more
openaire +5 more sources
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Emmet B. Keeffe +3 more
openaire +5 more sources
Hepatology, 2019
A dichotomous separation of hepatitis B viral DNA and hepatitis B surface antigen (HBsAg) concentrations occurs during the natural history and treatment of chronic hepatitis B.
I. Carey +7 more
semanticscholar +1 more source
A dichotomous separation of hepatitis B viral DNA and hepatitis B surface antigen (HBsAg) concentrations occurs during the natural history and treatment of chronic hepatitis B.
I. Carey +7 more
semanticscholar +1 more source